EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

COVID‐19 Vaccine mRNA Biodistribution: Maternal and Fetal Exposure Risks

Connie Zhong, Koral Cohen, Xinhua Lin, Emily Schiller, Surendra Sharma iD, Nazeeh Hanna iD

American Journal of Reproductive Immunology · 2024

DOI: 10.1111/aji.13934 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2024. Verfasst von Connie Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: New York University-Grossman Long Island School of Medicine, Mineola, New York, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Fetus, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS‐CoV‐2 infection during pregnancy has severe consequences on maternal and neonatal health. Presently, vaccination stands as a critical preventive measure for mitigating infection‐related risks. Although the initial clinical trials for the COVID‐19 vaccines excluded pregnant women, subsequent investigations have indicated mRNA vaccinations' effectiveness and short‐term safety during pregnancy. However, there is a lack of information regarding the potential biodistribution of the vaccine mRNA during pregnancy and lactation. Recent findings indicate that COVID‐19 vaccine mRNA has been detected in breast milk, suggesting that its presence is not confined to the injection site and raises the possibility of similar distribution to the placenta and the fetus. Furthermore, the potential effects and responses of the placenta and fetus to the vaccine mRNA are still unknown. While potential risks might exist with the exposure of the placenta and fetus to the COVID‐19 mRNA vaccine, the application of mRNA therapies for maternal and fetal conditions offers a groundbreaking prospect. Future research should leverage the unique opportunity provided by the first‐ever application of mRNA vaccines in humans to understand their biodistribution and impact on the placenta and fetus in pregnant women. Such insights could substantially advance the development of safer and more effective future mRNA‐based therapies during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19FetusSARS-CoV-2PlacentaPregnancy Complications, InfectiousHumansPregnancyFemalemRNA VaccinesRNA, MessengerTissue DistributionMilk, HumanVaccines, SyntheticVaccination

Stichwörter der Autor:innen

COVID‐19biodistributionlipid nanoparticlesneonateplacentapregnancyvaccine mRNA

Substanzen

COVID-19 VaccinesmRNA VaccinesRNA, MessengerVaccines, Synthetic

Autor:innen und Institutionen

  • New York University-Grossman Long Island School of Medicine, Mineola, New York, USA.
  • Women and Children's Research Laboratory, Departments of Foundations of Medicine, New York University-Grossman Long Island School of Medicine, Mineola, New York, USA.
  • Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Department of Pediatrics, Division of Neonatology, New York University Langone Hospital-Long Island, New York University-Grossman Long Island School of Medicine, Mineola, New York, USA.

ORCID-Profile: Surendra Sharma, Nazeeh Hanna

Förderung

  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute of Child Health and Human Development

Zitieren

APA

Zhong, C., Cohen, K., Lin, X., Schiller, E., Sharma, S., & Hanna, N. (2024). COVID‐19 Vaccine mRNA Biodistribution: Maternal and Fetal Exposure Risks. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13934

Vancouver

Zhong C, Cohen K, Lin X, Schiller E, Sharma S, Hanna N. COVID‐19 Vaccine mRNA Biodistribution: Maternal and Fetal Exposure Risks. American Journal of Reproductive Immunology. 2024. doi:10.1111/aji.13934

BibTeX
@article{Zhong2024,
  author = {Zhong, Connie and Cohen, Koral and Lin, Xinhua and Schiller, Emily and Sharma, Surendra and Hanna, Nazeeh},
  title = {COVID‐19 Vaccine mRNA Biodistribution: Maternal and Fetal Exposure Risks},
  journal = {American Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1111/aji.13934}
}
Kostenlos starten →